The Short Answer: A Stanford researcher has developed a blood test that measures cellular energy production in response to salt exposure — a promising biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Early results show cells from ME/CFS patients expend significantly more energy maintaining basic function, validating what patients experience as severe debilitation. This test could transform diagnosis, patient recognition, and research into autoimmune and post-viral fatigue conditions.

Understanding ME/CFS as a Cellular Energy Problem

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remains one of the most frustrating chronic conditions to diagnose and treat. Most physicians either dismiss it as psychiatric or don’t recognize it at all, despite evidence that it causes inflammation of the nervous system and measurable cellular dysfunction.

Until now, no diagnostic lab marker existed, leaving millions of autoimmune and post-viral patients without official validation of their condition. This gap in testing has created a vicious cycle: patients suffer without diagnosis, doctors remain skeptical, and research funding stays limited.

A Stanford scientist recently changed this trajectory by developing a simple blood test that measures cellular energy expenditure. The researcher’s personal motivation, his adult son has been largely bedbound with ME/CFS for over a decade, drove him to create what could become the first objective biomarker for the condition.

How the New Blood Test Works

The test measures how much energy cells must expend after exposure to salt. Salt creates osmotic stress, forcing cells to work harder to return to homeostasis. Healthy cells accomplish this task efficiently. Cells in people with ME/CFS and other chronic conditions must expend considerably more energy for the same job, a measurable sign of cellular dysfunction.

The scientist developed a microchip method that passes salt-exposed cells through a device that measures energy exertion via electrical current. The results are quantifiable and reproducible.

In the initial study, blood samples from 20 people with ME/CFS and 20 healthy controls showed striking differences: all 20 ME/CFS patients’ cells expended significantly more energy managing salt exposure compared to controls. This finding validates what patients report: their bodies are working harder just to maintain basic function.

Moving this test to clinical use requires larger studies demonstrating reproducibility across diverse populations. However, the initial results have energized both the scientific community and the ME/CFS patient population. A validated biomarker would mean:

• Patients finally receive proper diagnosis and medical recognition
• Doctors can distinguish ME/CFS from other conditions causing fatigue
• Research funding and treatment development accelerate dramatically

Avoiding Harmful Medical Advice for Autoimmune Fatigue

Because many conventional doctors lack knowledge about ME/CFS and autoimmune fatigue conditions, they often give advice that ranges from unhelpful to harmful. A common example: telling patients to exercise through their symptoms.

This recommendation misunderstands the core pathology. Autoimmune patients with ME/CFS are struggling to maintain basic functions of existence. Many cannot work, maintain normal activities, or leave their beds without consequences. Any exertion triggers post-exertion malaise, a crash period where symptoms worsen significantly and recovery takes days or weeks.

A doctor’s exercise prescription can substantially worsen debilitation rather than improve it.

ME/CFS involves far more than fatigue. Common symptoms include chronic pain, poor memory and cognition, gastrointestinal dysfunction, and sensitivities to light, sound, and smell. Though a symptom checklist exists for diagnosis, most primary care doctors remain unaware of it.

Brain Inflammation: A Unifying Factor in Chronic Fatigue

Emerging research on brain inflammation offers hope for people with ME/CFS and other autoimmune conditions. Brain inflammation connects to depression, anxiety, neurodevelopmental disorders, and neurodegenerative diseases, a pattern suggesting a common underlying mechanism.

Brain inflammation is far more prevalent than previously understood. The brain contains roughly 10 immune cells (microglia) for every neuron, and these cells play critical roles in brain health. They support neuron function and clear debris and protein buildup. However, poor diet, chronic stress, infections, or brain injury can trigger a shift: the brain’s immune cells switch from a supportive to a pro-inflammatory state.

Unlike the body’s immune system, the brain’s immune response has no natural “off switch.” This means neuroinflammation can persist like a slow-burning fire for years or decades, progressively damaging brain tissue and worsening symptoms.

The encouraging news: brain inflammation responds to botanical compounds, targeted nutrients, and functional medicine protocols that address diet, lifestyle, sleep, and stress management, even when conventional medications offer no solution.

Contact RedRiver Health and Wellness to work with a functional medicine doctor experienced in diagnosing and treating autoimmune fatigue and chronic conditions.